Live Breaking News & Updates on Errica Pharmaceuticals Aktie
Stay updated with breaking news from Errica pharmaceuticals aktie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
26.03.2024 - NCE status provides a minimum of five years of regulatory exclusivity The Company’s U.S. patents and pending patent applications related to YCANTH are projected to expire between 2034 and 2041, excluding any patent term adjustment or patent term . ....
29.01.2024 - WEST CHESTER, Pa., Jan. 29, 2024 (GLOBE NEWSWIRE) - Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today . Seite 1 ....
24.08.2023 - YCANTH is the first and only FDA-approved treatment for molluscum, a highly contagious viral skin infection affecting approximately 6 million people annually in the United States, primarily children FFF Enterprises is Verrica’s exclusive . Seite 1 ....